PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26400627-8	2015	But, the AMR, AR and CR groups have shown lower level of CD4(+)CD25(+)Foxp3(+) T cells and serum IL-10 compared to transplant stable (TS) patients.	Chromium	21-23	CD4 molecule	Homo sapiens	57-60	
24975341-3	2014	CD4/8 ratio in CR group was high compared to PR+NR group.	Chromium	15-17	CD4 molecule	Homo sapiens	0-3	
24490292-6	2013	RESULT: Patients with CRS had higher infiltration of the B lymphocytes (CD20) and T lymphocyte subsets (CD4, CD88) than the patients of the control group (P < 0.05).	Chromium	22-25	CD4 molecule	Homo sapiens	104-107	
22307765-9	2012	CD4 positivity correlated significantly with survival and CR durations, which were longer in patients with >=20% CD4+ cells than those with <20% CD4+ cells, thus indicating the prognostic value of CD4+ T cells in NHL patients.	Chromium	58-60	CD4 molecule	Homo sapiens	0-3	
22307765-9	2012	CD4 positivity correlated significantly with survival and CR durations, which were longer in patients with >=20% CD4+ cells than those with <20% CD4+ cells, thus indicating the prognostic value of CD4+ T cells in NHL patients.	Chromium	58-60	CD4 molecule	Homo sapiens	116-119	
22307765-9	2012	CD4 positivity correlated significantly with survival and CR durations, which were longer in patients with >=20% CD4+ cells than those with <20% CD4+ cells, thus indicating the prognostic value of CD4+ T cells in NHL patients.	Chromium	58-60	CD4 molecule	Homo sapiens	116-119	
22307765-9	2012	CD4 positivity correlated significantly with survival and CR durations, which were longer in patients with >=20% CD4+ cells than those with <20% CD4+ cells, thus indicating the prognostic value of CD4+ T cells in NHL patients.	Chromium	58-60	CD4 molecule	Homo sapiens	116-119	
17854443-4	2007	We show that CR is associated with a decreased number of CD4(+)CD25(high)FOXP3(+)T cells with normal regulatory profile, whereas graft acceptance is associated with CD4(+)CD25(high)FOXP3(+)T cell numbers similar to HVs.	Chromium	13-15	CD4 molecule	Homo sapiens	57-60	
16077928-5	2005	CR persisted in all 18 patients, including the 5 poor-risk KS patients in whom CR lasted for > 60 months, and was significantly linked to an increase in CD4+ cell counts and a drop in HIV-1-RNA copies.	Chromium	0-2	CD4 molecule	Homo sapiens	156-159	
16077928-5	2005	CR persisted in all 18 patients, including the 5 poor-risk KS patients in whom CR lasted for > 60 months, and was significantly linked to an increase in CD4+ cell counts and a drop in HIV-1-RNA copies.	Chromium	79-81	CD4 molecule	Homo sapiens	156-159	
15683452-6	2005	The level of CD4 and CD8 T lymphocytes in early apoptosis was higher in AR patients than in CR, SE or C groups (P <0.05).	Chromium	92-94	CD4 molecule	Homo sapiens	13-16	
15100465-1	2003	In previous work, guided ion beam tandem mass spectrometry has been used to study the reactions of the cluster cations of several transition metals (V, Cr, Fe and Ni) with D2, O2, CO2 and CD4.	Chromium	152-154	CD4 molecule	Homo sapiens	188-191	
11694949-5	2001	A 62% CR rate was achieved in 21 patients with a median CD4 count of 87/microL, and the median overall survival was 18 months.	Chromium	6-8	CD4 molecule	Homo sapiens	56-59	
10497290-7	1999	Only in revision surgery patients with high Cr concentrations did we find a significant decrease of lymphocytes, namely of CD4 and CD16 positive cells; revision surgery patients with normal Cr concentrations did not show a significant decrease of lymphocyte subpopulations.	Chromium	44-46	CD4 molecule	Homo sapiens	123-126	
8099750-5	1993	Significant increases in the Cho/Cr ratios were seen in patients with low CD4 lymphocyte counts and abnormal magnetic resonance (MR) images.	Chromium	33-35	CD4 molecule	Homo sapiens	74-77	
8429692-11	1993	The minimum CD4/CD8 ratio of peripheral mononuclear cells at remission was < 1.0 in all acute ATL long survivors with CR, and was > 1.0 in all acute ATL long survivors with PR.	Chromium	121-123	CD4 molecule	Homo sapiens	12-15	
31177975-10	2019	Furthermore, conditional knockout of ACC1 in CD4+ T cells attenuated the protection exerted by CR both on ischemic brain injury and peripheral balance of regulatory T cells/Th17 cells.	Chromium	95-97	CD4 molecule	Homo sapiens	45-48	
30364402-7	2018	Stepwise regression models showed that NAA/Cr alone best predicted CD4 nadir (beta = 40.1 +- 13.3; P = .005), whereas WMH (beta = 2.3 +- .9; P = .02) and mean cortical thickness (beta = -2.7 +- 6.6; P < .0001) together produced the best model fit with age.	Chromium	43-45	CD4 molecule	Homo sapiens	67-70	
30364402-8	2018	NAA/Cr was higher for HIV stage 1 (CD4 nadir >= 500 cells/ microL; n = 15) compared with stage 2 (200 >= CD4 nadir < 500; n = 13) and stage 3 (CD4 nadir < 200; n = 9; P < .01 for both).	Chromium	4-6	CD4 molecule	Homo sapiens	35-38